Real-World Health Outcomes of Insulin Glargine 300 U/mL vs Insulin Glargine 100 U/mL in Adults With Type 1 and Type 2 Diabetes in the Canadian LMC Diabetes Patient Registry: The REALITY Study
- Resource Type
- Article
- Authors
- Abitbol, Alexander; Brown, Ruth E.; Jiandani, Dishay; Sauriol, Luc; Aronson, Ronnie
- Source
- Canadian Journal of Diabetes; 20240101, Issue: Preprints
- Subject
- Language
- ISSN
- 14992671
This study evaluated real-world clinical outcomes of patients with type 1 diabetes (T1D) and type 2 diabetes (T2D) initiating or transferring to insulin glargine 300 U/mL (Gla-300) vs insulin glargine 100 U/mL (Gla-100).